"We are delighted to make Qutenza available for the many patients suffering from PHN and for the physicians looking for new ways to manage post-shingles pain," said Anthony DiTonno, president and chief executive officer, NeurogesX. "At NeurogesX, we have been committed to developing novel pain management therapies based on the power of prescription-strength capsaicin. Qutenza, which can provide patients with three months of pain relief, bears witness to the efficacy of capsaicin and the culmination of 10 years of work to bring this product to market for the benefit of PHN patients."Up to four Qutenza patches may be used and patches may be cut to conform to the size and shape of the painful area. Treatment with Qutenza may be repeated every three or more months as warranted by the return of pain, but not more frequently than every three months.
Qutenza(R) (capsaicin) 8% Patch For Treatment Of Post-Shingles Pain Now Available
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.